Cardiol Therapeutics (CRDL)
(Delayed Data from NSDQ)
$1.99 USD
+0.01 (0.51%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.98 -0.01 (-0.50%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.09 | 5.88% |
Earnings Summary
For their last quarter, Cardiol Therapeutics (CRDL) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.10 per share. This reflects a positive earnings surprise of 30.00%. Look out for CRDL's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year decrease of 28.57%.
Earnings History
Price & Consensus
Zacks News for CRDL
5 Small Drug Stocks to Buy From a Recovering Industry
CRDL: What are Zacks experts saying now?
Zacks Private Portfolio Services